NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Adaptyx Biosciences

Adaptyx Biosciences

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://adaptyx.bio/

Last Round

Seed

Oct 20, 2025

Total Funding Raised

$14M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Adaptyx Biosciences is a biotechnology company that develops a biowearable platform for continuous, multi-analyte molecular monitoring using synthetic DNA-based molecular switches and AI-powered analytics.

Sector

Healthcare & Life Sciences

Verticals

Health IoT, Medical Devices, Consumer Electronics, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Data as a Service

AI Layer

Infrastructure

Keywords

continuous biomarker monitoringwearable biosensorbiowearable platformDNA biosensorsmolecular switchesmulti-analyte monitoringAI-driven biosensor designwearable patchreal-time monitoringhealth insightshormone optimizationheart failure managementwellness trackingHealth IoTprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Adaptyx Biosciences Comparables

Compare Adaptyx Biosciences with similar companies based on industry and business-model similarity.

Adaptyx Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Level Zero Health
87%
Aptec Health
83%
Nutromics
82%

Adaptyx Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 20, 2025

Key People

Founding team and executive leadership

Alex Yoshikawa

Co-Founder and Chief Science Officer

Founding Team

Pawan Kapur

Co-Founder and CTO

Founding Team

Vijit Sabnis

Co-Founder, CEO

Founding Team

Adaptyx Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 22, 2025

    Developing a wearable patch for continuous biomarker monitoring.

  • Oct 20, 2025

    $14M raised in Seed round.

Adaptyx Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Adaptyx Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Adaptyx Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range17
Year Founded2022
Last FundingOct 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.